Novavax Inc.

NASDAQ: NVAX
Share price (12/20/24): $8.70
Market cap (12/20/24): $1.394 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023

ended 09/30/23 Q3

Prospectuses and Registrations Filter

Registration of securities for employees

Registration of securities for employees

Prospectus supplement for primary offering

Automatic shelf registration

Registration of securities for employees

Ownership Filter

Draghia-Akli Ruxandra

Draghia-Akli Ruxandra

Vanguard Group Inc

News Filter

Material Definitive Agreement

Material Definitive Agreement

Investor Presentation

U.S. FDA Removes Clinical Hold on Novavax’s COVID-19-Influenza Combination and Stand-Alone Influenza Phase 3 Trial

Reports Third Quarter 2024 Financial Results and Operational Highlights

Proxies Filter

Additional info about upcoming vote

Proxy materials by non-management

Proxy materials by non-management

Proxy materials by non-management

Proxy materials by non-management

Other Filter

Letter from the SEC

Scanned paper annual report submission

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC